Speaker illustration

Doctor Olgierd Wozniak

National Institute of Cardiology, Warsaw (Poland)

Member of:

European Society of Cardiology

NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Event: ESC Congress 2022

Topic: Biomarkers

Session: Biomarkers for heart failure 1

Thumbnail

This platform is supported by

logo Novo Nordisk